Avella Specialty Pharmacy registers with FDA as outsourcing facility for sterile compounding
PHOENIX — Avella Specialty Pharmacy on Tuesday announced that it has registered with the Food and Drug Administration as an outsourcing facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act. Outsource facilities must consent to greater federal oversight including more frequent inspections and are required to demonstrate their adherence to specific “good manufacturing practices,” Avella noted.
The new registration program was created to help healthcare providers, such as physicians and hospitals, identify a compounding pharmacy partner that meets high standards around quality control and patient safety.
“Avella has always welcomed new opportunities to illustrate the safety, efficacy and quality of our products,” stated Rebecca Shanahan, CEO of Avella. “We are excited to see that the FDA is looking to recognize facilities that have a commitment to excellence in these areas.”
NeoStrata introduces Skin Active Triple Firming Neck Cream
PRINCETON, N.J. — NeoStrata has announced the introduction of its new Skin Active Triple Firming Neck Cream, which is available exclusively through physician offices.
The new anti-aging formula is being unveiled at the 2014 American Academy of Dermatology winter academy meeting this week in Denver.
Skin Active Triple Firming Neck Cream is formulated with a blend of NeoStrata proprietary and other selectively sourced ingredients. According to the company, NeoGlucosamine helps increase hyaluronic acid and evens pigment, while NeoCitriate targets new collagen to lift and firm. Pro-amino acid increases pro-collagen to help diminish wrinkles. In addition, Swiss apple stem cell extract helps protect the longevity of skin’s essential cells, helping older cells behave like those in younger skin.
CHPA Educational Foundation Board announces board members
AMELIA ISLAND, Fla. — The Consumer Healthcare Products Association on Tuesday announced the members of the CHPA Educational Foundation Board during the association’s Annual Executive Conference held here.
“I welcome and thank our board members for their commitment, and I thank our chair, Chris DeWolf, for offering his continued support and leadership,” stated Emily Skor, VP communications and executive director, CHPA Educational Foundation. “With this strengthened support the foundation can enhance its consumer education, expanding on campaigns like our award-winning Up and Away and Out of Sight.”
The new board is part of CHPA’s commitment to expand the industry’s consumer education arm and ultimately contribute a greater impact on the responsible use, storage and disposal of consumer healthcare products in the years to come.
“This new board has the vision and expertise our industry needs to establish the foundation as the trusted source of information on the safe and responsible use of our products,” said Chris DeWolf, president and CEO of Lil’ Drug Store Products.
In addition to chairman DeWolf, CHPA Educational Foundation board members are:
- Maria Elisa Carvajal, VP and general manager of Colgate Oral Pharmaceuticals at the Colgate-Palmolive Co.;
- Brian Groves, chief marketing officer of the U.S. market at Pfizer Consumer Healthcare;
- Ernesto Levy, VP marketing of North America at Novartis Consumer Health;
- Scott Melville, president and CEO of Consumer Healthcare Products Association;
- Stephen Neumann, VP global marketing services at Merck Consumer Care;
- Jeffrey Needham, EVP and general manager of U.S. consumer healthcare at Perrigo Co.;
- Girard Smith, VP marketing of OTC at Bayer Healthcare; and
- David Tomasi, marketing director of Vicks North America at Procter & Gamble.